Dominant inhibitory mutations in the Mg2+-binding site of rasH prevent its activation by GTP

Molecular and Cellular Biology

Volumn 11, Issue 10, 1991, Pages 4822-4829

  Farnsworth, Charles L ^a   Feig, Larry A ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATE; MAGNESIUM; RAS PROTEIN;

ARTICLE; BINDING SITE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; ANIMAL; BINDING SITES; CELL LINE; GUANOSINE TRIPHOSPHATE; MAGNESIUM; MODELS, BIOLOGICAL; MUTATION; ONCOGENE PROTEIN P21(RAS); PHOSPHORYLATION; PRECIPITIN TESTS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025940096     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.11.10.4822     Document Type: Article

References (34)

1. Bourne, H. R., D. A. Sanders, and F. McCormick. 1990. The GTPase superfamily: a conserved switch for diverse cell functions. Nature (London) 348:125-132.
2. Broek, D., T. Toda, T. Michaeli, L. Levin, C. Birchmeier, M. Zoller, S. Powers, and M. Wigler. 1987. The S. cerevisiae CDC25 gene product regulates the Ral/adenylate cyclase pathway. Cell 48:789-799.
3. Cai, H., J. Szeberenyi, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-Ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10:5314-5323.
4. Cepko, C. L., B. Roberts, and R. C. Mulligan. 1984. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37:1053-1062.
5. Clanton, D. J., S. Hattori, and T. Y. Shin. 1986. Mutations of the ras gene product p21 abolish guanine nucleotide binding. Proc. Natl. Acad. Sci. USA 83:5076-5080.
6. Crechet, J.-B., P. Poullet, M. Y. Mistou, A. Parmeggiani, J. Camonis, E. Boy-Marcotte, F. Damak, and M. Jacquet. 1990. Enhancement of the GDP-GTP exchange of Ras proteins by the carboxyl-terminal domain of SCD25. Science 248:866-868.
7. Farnsworth, C. L., M. S. Marshal, J. B. Gibbs, D. W. Stacey, and L. A. Feig. 1991. Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/"effector" domain. Cell 64:625-633.
8. Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
9. Feig, L. A., and G. M. Cooper. 1988. Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol. Cell. Biol. 8:2472-2478.
10. Feig, L. A., B. T. Pan, T. M. Roberts, and G. M. Cooper. 1986. Isolation of ras GTP-binding mutants using an in situ colony-binding assay. Proc. Natl. Acad. Sci. USA 83:4607-4611.
11. Field, F., D. Broek, T. Kataoka, and M. Wigler. 1987. Guanine nucleotide activation of, and competition between, RAS proteins from Saccaromyces cerevisiae. Mol. Cell. Biol. 7:2128-2133.
12. Hagag, N., S. Halegoua, and M. Viola. 1986. Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature (London) 319:680-682.
13. s α prevents its activation by receptors. Mol. Cell. Biol. 11:4830-4838.
14. Kataoka, T., S. Powers, S. Cameron, O. Fasano, M. Goldfarb, J. Broach, and M. Wigler. 1985. Functional homology of mammalian and yeast RAS genes. Cell 44:19-26.
15. Masters, S. B., K. A. Sullivan, R. T. Miller, B. Beiderman, N. G. Lopez, J. Ramachandran, and H. R. Bourne. 1988. Carboxyl terminal domains of Gsα specifies coupling of receptors to stimulation of adenylyl cyclase. Science 241:939-945.
16. Milburn, M. V., L. Tong, A. M. DeVos, A. Brunger, Z. Yamaizumi, S. Nishimnra, and S. H. Kim. 1990. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science 247:939-945.
17. s chimera define the function of α chain domains in control of G protein activation and βγ subunit interactions. Cell 63:697-706.
18. Pal, E. F., U. Krengel, G. A. Petsko, R. S. Goody, W. Kabsch, and A. Wittinghofer. 1990. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 Å resolution: implications for the mechanism of GTP hydrolysis. EMBO J. 9:2351-2359.
19. Pai, F. E., W. Kabsch, U. Krengel, K. C. Holmes, J. John, and A. Wittinghofer. 1989. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature (London) 341:209-214.
20. Powers, S., K. O'Neill, and M. Wigler. 1989. Dominant yeast and mammalian Ras mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae. Mol. Cell. Biol. 9:390-395.
21. Rapp, U. R., M. D. Goldborough, G. E. Mark, T. I. Bonna, J. Groffen, F. H. Reynolds, and J. R. Stephenson. 1983. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. USA 80:4218-4222.
22. Salomon, Y. 1979. Adenylyl cyclase assay. Adv. Cyclic Nucleotide Res. 10:35-54.
23. Saraste, M., P. R. Sibbald, and A. Wittinghofer. 1990. The P-loop - a common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci. 15:430-434.
24. Schaber, M. D., V. M. Garsky, D. B. Boylon, W. S. Hill, E. M. Scolnick, M. S. Marshall, I. S. Sigal, and J. B. Gibbs. 1989. Ras interactions with the GTPase-activating protein (GAP). Proteins Struct. Funct. Genet. 6:306-315.
25. Schlichting, I., S. C. Almo, G. Rapp, K. Wilson, K. Petratos, A. Lentfer, A. Wittinghofer, W. Kabsch, E. F. Pai, G. A. Petsko, and R. S. Goody. 1980. Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis. Nature (London) 345:309-316.
26. Shalloway, D., A. D. Zelenetz, and G. M. Cooper. 1980. Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus. Cell 24:531-541.
27. Shih, T. Y., A. G. Papageorge, P. E. Stokes, M. O. Weeks, and E. M. Scolnick. 1980. Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus. Nature (London) 287:686-691.
28. Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540-543.
29. Stacey, D. W., L. A. Feig, and J. B. Gibbs. 1991. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11:4053-4064.
30. Szeberenyi, J., H. Cai, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10:5324-5332.
31. Trahey, M., and F. McConnick. 1987. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238:542-545.
32. West, M., H. F. Kung, and T. Kamata. 1990. A novel membrane factor stimulates guanine nucleotide exchange reaction of ras proteins. FEB Lett. 259:245-248.
33. Wolfman, A., and L. A. Feig. Unpublished data.
34. Wolfman, A., and I. G. Macara. 1990. A cytosolic protein catalyzes the release of GDP from p21. Science 248:247-249.